Grail’s (GRAL) stock is dropping 6% after the company reported fourth-quarter revenue above analysts’ average estimate and noted that Tricare, a large health insurance provider, had decided to ...

Grail’s (GRAL) stock is dropping 6% after the company reported fourth-quarter revenue above analysts’ average estimate and noted that Tricare, a large health insurance provider, had decided to ...

Grail (GRAL) is jumping for a second straight day, climbing 6% today, after Oracle (ORCL) Chairman Larry Ellison on Tuesday said that blood tests that detect small tumor fragments could be used ...

Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand provider access to Grail's Galleri multi-cancer early detection test.

Especially high volume was seen for the $45 strike call option expiring May 16, 2025, with 1,591 contracts trading so far today, representing approximately 159,100 underlying shares of GRAL.